population health

News

Practice Patterns, Predictors of Survival for Older Patients With MCL

05/27/2020

A new study assessed clinical outcomes and predictors of survival in older patients with mantle cell lymphoma (MCL) treated in the rituximab era. Results of the study are to be presented at the American Society of...

A new...

05/27/2020

Journal of Clinical Pathways

Perspectives

Rationale for the Development of Clinical Pathways and an Overview of the Clinical Pathways Office at the Seattle Cancer Care Alliance

09/19/2017

Sanu Jain, BS, MHA

Abstract: The United States health care system continues moving away from an unsustainable fee-for-service payment model to more novel measures of care delivery. Clinical pathways have emerged as one of the...

...

09/19/2017

Journal of Clinical Pathways

Research in Review

Patient Values, Concerns Influence Breast Cancer Treatment Decisions

08/17/2017

JCP Editors

Researchers examined the decision-making processes of patients with breast cancer to understand why a procedure that does not improve survival is increasingly being considered. ----- Related Content Contralateral...

...

08/17/2017

Journal of Clinical Pathways

Feature

Multidisciplinary Management of Multiple Myeloma in Older Adults

08/17/2017

Nader Tavakoli, MD, CMD, FAAFP

Sidrah Khan, MD

Shelby Knowles, MD

Richard Stefanacci, DO, MGH, MBA, AGSF, CMD

Abstract: Multiple myeloma (MM) is a progressive and fatal disease, primarily affecting men aged 66 years or older. Because MM is primarily a disease of the elderly, it is incumbent on geriatricians and primary care...

...

08/17/2017

Journal of Clinical Pathways

Research in Review

Pediatric APL Outcomes Improved By Arsenic Trioxide Consolidation

08/03/2017

JCP Editors

Consolidation with arsenic trioxide allows for decreased anthracycline dosing while maintaining survival rates and a low risk of relapse in pediatric patients with acute promyelocytic leukemia (APL), according to a...

...

08/03/2017

Journal of Clinical Pathways

Research in Review

Older Patients With Advanced-Stage Rectal Cancer Often Receive Sub-Optimal Treatment

08/01/2017

JCP Editors

A majority of older patients with stage II or III rectal adenocarcinoma do not receive standard-of-care treatment, according to recent research published in Cancer (online July 31, 2017;...

A...

08/01/2017

Journal of Clinical Pathways

Research in Review

Clinical Trial Efficacy Consistent with Real-World Outcomes, Study Shows

07/28/2017

JCP Editors

Researchers compared the relationship between randomized controlled clinical trial efficacy data and real-world effectiveness for oncology therapies, published in Value in Health (July-August,...

...

07/28/2017

Journal of Clinical Pathways

Research in Review

ADT Plus Combination Therapy Improves Outcomes in Metastatic Prostate Cancer

07/28/2017

JCP Editors

A combination regimen plus androgen-deprivation therapy prolongs overall survival (OS) and radiographic progression-free survival (PFS) in newly diagnosed patients with metastatic, castration-sensitive prostate...

A...

07/28/2017

Journal of Clinical Pathways

Research in Review

High-Priority Areas for Quality Improvement Identified for Breast Cancer Treatment

07/26/2017

JCP Editors

Researchers identified three quality measures that have the largest potential of improving quality of care at a system level for patients with early-stage breast cancer receiving systemic therapy. ----- Related...

...

07/26/2017

Journal of Clinical Pathways

Research in Review

Predictor of Aggressive Disease in Multiple Myeloma Identified

07/18/2017

JCP Editors

Certain patients with multiple myeloma often have poorer outcomes, according to a recent meta-analysis. ----- Related Content Circulating tumor cells may help guide bladder cancer treatment Plasma ghrelin levels...

...

07/18/2017

Journal of Clinical Pathways